Source:http://linkedlifedata.com/resource/pubmed/id/10796584
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2000-7-6
|
| pubmed:abstractText |
Mecamylamine is a nicotine antagonist (that is it blocks the effect of nicotine). The rationale for its use in smoking cessation is that it may block the rewarding effect of nicotine and thus reduce the urge to smoke.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1469-493X
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
CD001009
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:10796584-Administration, Cutaneous,
pubmed-meshheading:10796584-Drug Therapy, Combination,
pubmed-meshheading:10796584-Humans,
pubmed-meshheading:10796584-Mecamylamine,
pubmed-meshheading:10796584-Nicotine,
pubmed-meshheading:10796584-Nicotinic Antagonists,
pubmed-meshheading:10796584-Smoking,
pubmed-meshheading:10796584-Smoking Cessation
|
| pubmed:year |
2000
|
| pubmed:articleTitle |
Mecamylamine (a nicotine antagonist) for smoking cessation.
|
| pubmed:affiliation |
ICRF General Practice Research Group, Division of Public Health and Primary Health Care, Institute of Health Sciences, Old Road, Headington, Oxford, UK, OX3 7LF. tim.lancaster@dphpc.ox.ac.uk
|
| pubmed:publicationType |
Journal Article,
Comparative Study,
Review
|